Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
PurposeSince the clinical introduction of 68Ga-PSMA-11 PET/CT, this imaging method has rapidly spread and is now regarded as a significant step forward in the diagnosis of recurrent prostate cancer (PCa). The aim of this study was to analyse the influence of several variables with possible influence...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 May 2017
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2017, Jahrgang: 44, Heft: 8, Pages: 1258-1268 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-017-3711-7 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00259-017-3711-7 Verlag, Volltext: https://link.springer.com/article/10.1007/s00259-017-3711-7 
|
| Verfasserangaben: | Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L. Giesel, Clemens Kratochwil, Walter Mier, Sabine Haufe, Nils Debus, Matthias Eder, Michael Eisenhut, Martin Schäfer, Oliver Neels, Markus Hohenfellner, Klaus Kopka, Hans-Ulrich Kauczor, Jürgen Debus, Uwe Haberkorn |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572118091 | ||
| 003 | DE-627 | ||
| 005 | 20230426124246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180418s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-017-3711-7 |2 doi | |
| 035 | |a (DE-627)1572118091 | ||
| 035 | |a (DE-576)502118091 | ||
| 035 | |a (DE-599)BSZ502118091 | ||
| 035 | |a (OCoLC)1341007038 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Afshar-Oromieh, Ali |d 1975- |e VerfasserIn |0 (DE-588)130260436 |0 (DE-627)496579711 |0 (DE-576)189580003 |4 aut | |
| 245 | 1 | 0 | |a Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer |b evaluation in 1007 patients |c Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L. Giesel, Clemens Kratochwil, Walter Mier, Sabine Haufe, Nils Debus, Matthias Eder, Michael Eisenhut, Martin Schäfer, Oliver Neels, Markus Hohenfellner, Klaus Kopka, Hans-Ulrich Kauczor, Jürgen Debus, Uwe Haberkorn |
| 246 | 3 | 3 | |a Diagnostic performance of 68 Ga-PSMA-11 |
| 264 | 1 | |c 12 May 2017 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Titel ist die Zahl 68 hochgesetllt | ||
| 500 | |a Gesehen am 18.04.2018 | ||
| 520 | |a PurposeSince the clinical introduction of 68Ga-PSMA-11 PET/CT, this imaging method has rapidly spread and is now regarded as a significant step forward in the diagnosis of recurrent prostate cancer (PCa). The aim of this study was to analyse the influence of several variables with possible influence on PSMA ligand uptake in a large cohort.MethodsWe performed a retrospective analysis of 1007 consecutive patients who were scanned with 68Ga-PSMA-11 PET/CT (1 h after injection) from January 2014 to January 2017 to detect recurrent disease. Patients with untreated primary PCa or patients referred for PSMA radioligand therapy were excluded. The possible effects of different variables including PSA level and PSA doubling time (PSADT), PSA velocity (PSAVel), Gleason score (GSC, including separate analysis of GSC 7a and 7b), ongoing androgen deprivation therapy (ADT), patient age and amount of injected activity were evaluated.ResultsIn 79.5% of patients at least one lesion with characteristics suggestive of recurrent PCa was detected. A pathological (positive) PET/CT scan was associated with PSA level and ADT. GSC, amount of injected activity, patient age, PSADT and PSAVel were not associated with a positive PET/CT scan in multivariate analysis.Conclusion 68Ga-PSMA-11 PET/CT detects tumour lesions in a high percentage of patients with recurrent PCa. Tumour detection is clearly associated with PSA level and ADT. Only a tendency for an association without statistical significance was found between higher GSC and a higher probability of a pathological PET/CT scan. No associations were found between a pathological 68Ga-PSMA-11 PET/CT scan and patient age, amount of injected activity, PSADT or PSAVel. | ||
| 700 | 1 | |a Giesel, Frederik L. |d 1970- |e VerfasserIn |0 (DE-588)129031240 |0 (DE-627)387883878 |0 (DE-576)297457071 |4 aut | |
| 700 | 1 | |a Kratochwil, Clemens |d 1978- |e VerfasserIn |0 (DE-588)134026276 |0 (DE-627)559871686 |0 (DE-576)300262787 |4 aut | |
| 700 | 1 | |a Mier, Walter |d 1966- |e VerfasserIn |0 (DE-588)12029026X |0 (DE-627)69653567X |0 (DE-576)292141599 |4 aut | |
| 700 | 1 | |a Haufe, Sabine |e VerfasserIn |0 (DE-588)1032764899 |0 (DE-627)739277200 |0 (DE-576)380272318 |4 aut | |
| 700 | 1 | |a Hohenfellner, Markus |d 1958- |e VerfasserIn |0 (DE-588)133862518 |0 (DE-627)557857988 |0 (DE-576)300155263 |4 aut | |
| 700 | 1 | |a Kauczor, Hans-Ulrich |d 1962- |e VerfasserIn |0 (DE-588)139267123 |0 (DE-627)70327113X |0 (DE-576)310955327 |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Heidelberg [u.a.] : Springer-Verl., 2002 |g 44(2017), 8, Seite 1258-1268 |h Online-Ressource |w (DE-627)359787258 |w (DE-600)2098375-X |w (DE-576)110279549 |x 1619-7089 |7 nnas |a Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer evaluation in 1007 patients |
| 773 | 1 | 8 | |g volume:44 |g year:2017 |g number:8 |g pages:1258-1268 |g extent:11 |a Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer evaluation in 1007 patients |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00259-017-3711-7 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00259-017-3711-7 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180418 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 16 |y j | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 15 | ||
| 998 | |g 139267123 |a Kauczor, Hans-Ulrich |m 139267123:Kauczor, Hans-Ulrich |d 910000 |d 911400 |e 910000PK139267123 |e 911400PK139267123 |k 0/910000/ |k 1/910000/911400/ |p 14 | ||
| 998 | |g 133862518 |a Hohenfellner, Markus |m 133862518:Hohenfellner, Markus |d 910000 |d 910200 |e 910000PH133862518 |e 910200PH133862518 |k 0/910000/ |k 1/910000/910200/ |p 12 | ||
| 998 | |g 1032764899 |a Haufe, Sabine |m 1032764899:Haufe, Sabine |d 910000 |d 911400 |e 910000PH1032764899 |e 911400PH1032764899 |k 0/910000/ |k 1/910000/911400/ |p 6 | ||
| 998 | |g 12029026X |a Mier, Walter |m 12029026X:Mier, Walter |d 910000 |d 911400 |e 910000PM12029026X |e 911400PM12029026X |k 0/910000/ |k 1/910000/911400/ |p 5 | ||
| 998 | |g 134026276 |a Kratochwil, Clemens |m 134026276:Kratochwil, Clemens |d 910000 |d 911400 |e 910000PK134026276 |e 911400PK134026276 |k 0/910000/ |k 1/910000/911400/ |p 4 | ||
| 998 | |g 129031240 |a Giesel, Frederik L. |m 129031240:Giesel, Frederik L. |d 910000 |d 911400 |e 910000PG129031240 |e 911400PG129031240 |k 0/910000/ |k 1/910000/911400/ |p 3 | ||
| 998 | |g 130260436 |a Afshar-Oromieh, Ali |m 130260436:Afshar-Oromieh, Ali |p 1 |x j | ||
| 999 | |a KXP-PPN1572118091 |e 3006355229 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title_sort":"Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer","subtitle":"evaluation in 1007 patients","title":"Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer"}],"titleAlt":[{"title":"Diagnostic performance of 68 Ga-PSMA-11"}],"person":[{"family":"Afshar-Oromieh","given":"Ali","display":"Afshar-Oromieh, Ali","role":"aut"},{"role":"aut","display":"Giesel, Frederik L.","given":"Frederik L.","family":"Giesel"},{"given":"Clemens","display":"Kratochwil, Clemens","family":"Kratochwil","role":"aut"},{"display":"Mier, Walter","given":"Walter","family":"Mier","role":"aut"},{"given":"Sabine","display":"Haufe, Sabine","family":"Haufe","role":"aut"},{"given":"Markus","display":"Hohenfellner, Markus","family":"Hohenfellner","role":"aut"},{"family":"Kauczor","display":"Kauczor, Hans-Ulrich","given":"Hans-Ulrich","role":"aut"},{"family":"Debus","given":"Jürgen","display":"Debus, Jürgen","role":"aut"},{"given":"Uwe","display":"Haberkorn, Uwe","family":"Haberkorn","role":"aut"}],"recId":"1572118091","name":{"displayForm":["Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L. Giesel, Clemens Kratochwil, Walter Mier, Sabine Haufe, Nils Debus, Matthias Eder, Michael Eisenhut, Martin Schäfer, Oliver Neels, Markus Hohenfellner, Klaus Kopka, Hans-Ulrich Kauczor, Jürgen Debus, Uwe Haberkorn"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"12 May 2017"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["359787258"],"issn":["1619-7089"],"zdb":["2098375-X"]},"part":{"issue":"8","extent":"11","pages":"1258-1268","year":"2017","volume":"44","text":"44(2017), 8, Seite 1258-1268"},"note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"origin":[{"dateIssuedKey":"2002","publisherPlace":"Heidelberg [u.a.]","publisher":"Springer-Verl.","dateIssuedDisp":"2002-"}],"title":[{"subtitle":"official journal of the European Association of Nuclear Medicine (EANM)","title_sort":"European journal of nuclear medicine and molecular imaging","title":"European journal of nuclear medicine and molecular imaging"}],"pubHistory":["29.2002 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"359787258","disp":"Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer evaluation in 1007 patientsEuropean journal of nuclear medicine and molecular imaging","language":["eng"]}],"note":["Im Titel ist die Zahl 68 hochgesetllt","Gesehen am 18.04.2018"],"physDesc":[{"extent":"11 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1007/s00259-017-3711-7"],"eki":["1572118091"]}} | ||
| SRT | |a AFSHAROROMDIAGNOSTIC1220 | ||